You are here

  • Overview
  • Registration & Abstract
  • Agenda
  • Location
  • Contact
  • 8:00 AM to 4:00 PM
  • 89 Chestnut Street
    Toronto, Ontario
    M5G 1R1

Welcome to the 2016 Krembil Research Day website. This annual event celebrates our achievements in basic and clinical research. Krembil Research Day has a strong history, with participation from researchers, clinicians, trainees and Krembil staff.  This year, Research Day will be held on Wednesday, May 18th, at the Chestnut Residence & Conference Centre located at 89 Chestnut Street in Toronto.

Everyone is welcome to submit an abstract for a poster presentation, however only trainees may submit abstracts for oral presentations. If you plan to submit an abstract, please register only when your abstract is ready as both processes are done at the same time.  If you are not submitting an abstract, please register as soon as possible.  Due to space limitations, only one first-authored abstract per registrant can be submitted.

Please mark your calendars for May 18th and we look forward to seeing you there!

Oral and Poster Abstract Submission Deadline:  Thursday, March 31, 2016 at 4:00 pm.
Registration Closes:  Friday, April 29, 2016 at 4:00 pm.

Online registration is mandatory for all abstracts and general attendees.


Registration for the 2016 Krembil Research Day is now open.  You must register in advance if you wish to attend as we need to plan for seating, catering, printing of programs, etc.  The deadline to register has now passed.


Abstract submissions are due by Thursday, March 31, 2016 at 4:00 pm.  No late submissions will be accepted.

If you wish to submit a first-authored abstract for the poster presentation, please note that abstract submission and registration are part of the same process. Please register only if your abstract is also ready for submission.  Please note: if the same abstract is submitted more than once, the last submission will be considered the final submission which will be used for the booklet and judging.

Submission Instructions:
Abstract: Your abstract must not exceed a maximum of 300 words (2000 characters including spaces). Please do not use special symbols, Greek characters, super- and sub-scripts as they will not be preserved in the online submission process. Only one first-authored abstract per registrant may be submitted. You must be the presenting author and the first author in order to be judged in Krembil Research Institute's poster competition.

Abstract Format: Abstracts must be in a standarized format with the following subheadings: Hypothesis, Materials and Methods, Results, and Conclusion.

Abstract Authors: Please type in all names using the first initial followed by the author's last name. A comma should separate author names and the final name should be followed by a period.
For example: SR Wilson, MK O'Reilly, JP Leduc, and BA Bell.

Affiliations: Please type in all affiliations. A comma should separate each affiliation and the final affiliation should be followed by a period.
For example: Krembil Research Institute, Toronto, ON and University of Toronto, Toronto, ON.

We invite everyone to submit an abstract for a poster or oral presentation. Please note that only trainees (senior undergraduate project students, graduate students, post-doctoral fellows, and clinical fellows) submitting first-author abstracts will be considered for an oral presentation and judged for their oral/poster presentation. Prizes will be awarded for the top posters and oral presentations from the Institute.

Poster Details:
Size (height x length): 3' x 6' (36" x 72") (Posterboard Size: 1m x 2m)

If you have any questions, please contact Julie Wan at


Dr. Betty Diamond, MD
Investigator & Head, Center for Autoimmune and Musculoskeletal Diseases
The Feinstein Institute for Medical Research
Professor of Molecular Medicine and Medicine, Hofstra Northwell Health School of Medicine
Manhasset, New York

Dr. Betty Diamond received her MD from Harvard Medical School and performed a residency in Internal Medicine at Columbia Presbyterian Medical Center.  She received her rheumatology training at the Albert Einstein College of Medicine where she also performed postdoctoral research in the laboratory of Dr. Matthew Scharff.  She has been Chief of Rheumatology at Albert Einstein and Columbia University and is currently Head of the Center for Autoimmune and Musculoskeletal Diseases at the Feinstein Institute for Medical Research.
Her research has focused on the induction and pathogenicity of autoantibodies in Systemic Lupus Erythematosus (SLE). She demonstrated that autoreactivity can be generated by somatic mutation and that anti-DNA antibodies that cross-react with the NMDA receptor can cause manifestations of neuropsychiatric lupus.  Most recently, she has become interested in the anti-inflammatory effects of C1q, has identified LAIR-1 as an inhibitory cellular receptor for C1q and has shown that it functions to impede monocyte activation and differentiation. In recent years, she has also become involved in clinical trials in SLE and has led several clinical trials of novel therapeutics.
Dr. Diamond has served on several committees of the American College of Rheumatology (ACR) and has served on the Board of Directors as well. She has received the Outstanding Investigator and Mentoring Award of ACR.  She is a member of the National Academy of Medicine and past president of the American Association of Immunologists.



The 2016 Krembil Research Day will be held at the Chestnut Residence & Conference Centre, located at 89 Chestnut St - a 7 minute walk from PMH/TGH/MaRS. 
Oral and poster presentations will take place in the Colony Ballroom on the 2nd floor; Reception with Dr. Diamond will take place in the Lombard Suite on the 2nd floor.


Research Day comments and inquiries should be sent to the Krembil Directorate Office at

Wednesday, May 18, 2016 - 08:00 to 16:00